What does Dr. Pieter Koopman do?

Dr. Pieter Koopman is a specialist medical practice in Heusden-Zolder. Private Limited, started on 28 October 2011, 1 establishment.

What is the address of Dr. Pieter Koopman?

The registered office of Dr. Pieter Koopman is located at Lobelialaan 11, 3550 Heusden-Zolder.

Is Dr. Pieter Koopman still active?

Yes. According to the CBE (16 September 2026) Dr. Pieter Koopman is active, legal situation “Normale toestand”, started on 28 October 2011.

Is Dr. Pieter Koopman registered on Peppol?

Yes, Dr. Pieter Koopman is registered on the Peppol network with ID 0208:0841170538.

What is the enterprise number of Dr. Pieter Koopman?

The enterprise number of Dr. Pieter Koopman is BE0841170538.

When was Dr. Pieter Koopman founded?

Dr. Pieter Koopman was founded on 28 October 2011.

Who are the directors of Dr. Pieter Koopman?

According to the 2024 annual accounts, the directors of Dr. Pieter Koopman are: Pieter Koopman.

Is Dr. Pieter Koopman a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 October 2011; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Dr. Pieter Koopman make in 2024?

Dr. Pieter Koopman posted a profit after taxes of € 335,424 in financial year 2024.

What is the revenue of Dr. Pieter Koopman?

As a small company, Dr. Pieter Koopman is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 667,627.

Dr. Pieter Koopman (Private Limited) - Heusden-Zolder

Dossier Dr. Pieter Koopman, printed on 16 September 2026 from databakkes.be/en/0841170538/dr-pieter-koopman. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dr. Pieter Koopman from Heusden-Zolder, company number BE0841170538, closed financial year 2024 with a result of € 335,424 after tax. For that financial year Dr. Pieter Koopman recorded a gross margin of € 667,627 and equity of € 1.4 million. Compared with financial year 2023, the result moved from € 204,359 to € 335,424. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.

What it is worth Healthy

€ 1.4 million

▼ 6% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 335,424

▲ 64% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 154,701

▼ 7% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 414,500 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Wage cost

€ 17,944

▼ 14% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 56,563

▼ 27% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.1 million

▼ 10% vs 2023

€ 132,714 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 1,988

▼ 25% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 84,349

▲ 211% vs 2023

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 462,133 Gross margin 2021: € 462,133 First fiscal year in the series	€ 445,763 Gross margin 2022: € 445,763 ▼ 4% vs 2021 (€ 462,133) Unfavourable step	€ 463,604 Gross margin 2023: € 463,604 ▲ 4% vs 2022 (€ 445,763) Favourable step	€ 667,627 Gross margin 2024: € 667,627 ▲ 44% vs 2023 (€ 463,604) Favourable step	▲ 44%
Profit after taxes	€ 201,901 Profit after taxes 2021: € 201,901 First fiscal year in the series	€ 168,876 Profit after taxes 2022: € 168,876 ▼ 16% vs 2021 (€ 201,901) Unfavourable step	€ 204,359 Profit after taxes 2023: € 204,359 ▲ 21% vs 2022 (€ 168,876) Favourable step	€ 335,424 Profit after taxes 2024: € 335,424 ▲ 64% vs 2023 (€ 204,359) Favourable step	▲ 64%
Equity	€ 1,058,627 Equity 2021: € 1,058,627 First fiscal year in the series	€ 1,227,504 Equity 2022: € 1,227,504 ▲ 16% vs 2021 (€ 1,058,627) Favourable step	€ 1,431,863 Equity 2023: € 1,431,863 ▲ 17% vs 2022 (€ 1,227,504) Favourable step	€ 1,352,786 Equity 2024: € 1,352,786 ▼ 6% vs 2023 (€ 1,431,863) Unfavourable step	▼ 6%
Total debts	€ 1,360,178 Total debts 2021: € 1,360,178 First fiscal year in the series	€ 1,274,237 Total debts 2022: € 1,274,237 ▼ 6% vs 2021 (€ 1,360,178) Favourable step	€ 1,201,951 Total debts 2023: € 1,201,951 ▼ 6% vs 2022 (€ 1,274,237) Favourable step	€ 1,499,582 Total debts 2024: € 1,499,582 ▲ 25% vs 2023 (€ 1,201,951) Unfavourable step	▲ 25%
Cash	€ 620,033 Cash 2021: € 620,033 First fiscal year in the series	€ 246,966 Cash 2022: € 246,966 ▼ 60% vs 2021 (€ 620,033) Unfavourable step	€ 165,656 Cash 2023: € 165,656 ▼ 33% vs 2022 (€ 246,966) Unfavourable step	€ 154,701 Cash 2024: € 154,701 ▼ 7% vs 2023 (€ 165,656) Unfavourable step	▼ 7%
Land & buildings	€ 1,648,478 Land & buildings 2021: € 1,648,478 First fiscal year in the series	€ 1,533,243 Land & buildings 2022: € 1,533,243 ▼ 7% vs 2021 (€ 1,648,478) Unchanged	€ 1,408,852 Land & buildings 2023: € 1,408,852 ▼ 8% vs 2022 (€ 1,533,243) Unchanged	€ 1,290,425 Land & buildings 2024: € 1,290,425 ▼ 8% vs 2023 (€ 1,408,852) Unchanged	▼ 8%
Retained profit	€ 1,046,227 Retained profit 2021: € 1,046,227 First fiscal year in the series	€ 1,215,104 Retained profit 2022: € 1,215,104 ▲ 16% vs 2021 (€ 1,046,227) Favourable step	€ 1,419,463 Retained profit 2023: € 1,419,463 ▲ 17% vs 2022 (€ 1,215,104) Favourable step	€ 1,340,386 Retained profit 2024: € 1,340,386 ▼ 6% vs 2023 (€ 1,419,463) Unfavourable step	▼ 6%
Dividend	€ 115,500 Dividend 2021: € 115,500 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 115,500) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 414,500 Dividend 2024: € 414,500 Unchanged (€ 0) Unchanged
Bank debt	€ 1,310,948 Bank debt 2021: € 1,310,948 First fiscal year in the series	€ 1,216,340 Bank debt 2022: € 1,216,340 ▼ 7% vs 2021 (€ 1,310,948) Favourable step	€ 1,172,206 Bank debt 2023: € 1,172,206 ▼ 4% vs 2022 (€ 1,216,340) Favourable step	€ 1,060,470 Bank debt 2024: € 1,060,470 ▼ 10% vs 2023 (€ 1,172,206) Favourable step	▼ 10%
Balance sheet total	€ 2,418,805 Balance sheet total 2021: € 2,418,805 First fiscal year in the series	€ 2,501,741 Balance sheet total 2022: € 2,501,741 ▲ 3% vs 2021 (€ 2,418,805) Unchanged	€ 2,633,814 Balance sheet total 2023: € 2,633,814 ▲ 5% vs 2022 (€ 2,501,741) Unchanged	€ 2,852,368 Balance sheet total 2024: € 2,852,368 ▲ 8% vs 2023 (€ 2,633,814) Unchanged	▲ 8%

Key figures of Dr. Pieter Koopman, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. Pieter Koopman?

What happened at Dr. Pieter Koopman in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2025 New annual accounts for financial year 2024: profit of € 335,424 (▲ 64% vs 2023). filed late Source: NBB ↗
Nov 18, 2011 New establishment in Heusden-Zolder. KBO
Oct 28, 2011 Start of the company according to the CBE. KBO

In short

From € 201,901 profit in 2021 to € 335,424 profit in 2024.

Paid € 417,971 in corporate taxes since 2021.

Best year ever: 2024, with € 335,424 profit.

Paid out € 530,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Pieter Koopman? We notify you, reason included.

Follow Dr. Pieter Koopman

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Pieter Koopman

Dr. Pieter Koopman

HHH 6%

Behind Dr. Pieter Koopman is Pieter Koopman. It owns 6% of HHH itself.

See the full network in the app

Directors

According to the 2024 annual accounts

Pieter Koopman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Lobelialaan 11

3550 Heusden-Zolder

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0841.170.538

VAT number

BE 0841.170.538

Registered office

Lobelialaan 11, 3550 Heusden-Zolder

Names & denominations

Dr. Pieter Koopman

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 October 2011

Peppol

Active · Active since 25 Feb 2026

Activities · NACE

Activiteiten van medisch specialisten

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Overige vormen van onderwijs

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Pieter Koopman

Financials

What happened to Dr. Pieter Koopman?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions